Jane Scheetz

Jane Scheetz

Auto-generated profile, based on publicly available information

Jane Scheetz

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2019 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SKStuart Keel
Stuart Keel
ZLZhixi Li
Zhixi Li
JSJane Scheetz
Jane Scheetz
LRLiubov Robman
Liubov Robman
JPJames Phung
James Phung
MHMingguang He
Mingguang He

19 October 2020 in Eye
Verified
Journal Article
Closed access
PDF file
LWLanhua Wang
Lanhua Wang
ZZZhuoting Zhu
Zhuoting Zhu
JSJane Scheetz
Jane Scheetz
MHMingguang He
Mingguang He

18 July 2019 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
ZZZhuoting Zhu
Zhuoting Zhu
WWWei Wang
Wei Wang
JSJane Scheetz
Jane Scheetz
JZJian Zhang
Jian Zhang
MHMingguang He
Mingguang He
Importance: Recent US national population‐based data on the prevalence of retinopathy in non‐diabetic participants is limited.Background: To assess the prevalence and risk factors of retinopathy in a representative US population without diabetes.Design: Population‐based, cross‐sectional study.Participants: A total of 4354 non‐diabetic participants 40 years and older with valid fundus photographs in the 2005 to 2008 National Health and Nutrition Examination Survey.Methods: Diabetes mellitus was defined as glycosylated haemoglobin (HbA1c) ≥6.5%, physician diagnosis of diabetes mellitus or use of diabetic medication. Retinopathy level was based on the Modified Airlie House adaptation from the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Risk profile was assessed from standardized interviews, clinical examinations and laboratory measurements.Main Outcome Measures: Prevalence and risk profile of retinopathy in non‐diabetic participants.Results: The overall weighted prevalence of retinopathy was 6.7% (n = 341). Among them, 98.2% (n = 331) had signs of minimal‐to‐mild non‐proliferative retinopathy (ETDRS level 14‐31) while only 1.8% (n = 10) had moderate‐to‐severe non‐proliferative retinopathy (ETDRS level 41‐51). After adjusting for multiple covariates, retinopathy signs in non‐diabetic participants were associated with male gender (odds ratio [OR] 1.54; 95% confidence interval [CI] 1.22–1.93), systolic blood pressure (OR per 10 mmHg increase 1.11; 95% CI 1.03–1.19), HbA1c (OR per % increase 1.43; 95% CI 1.01–2.05) and history of stroke (OR 2.39; 95% CI 1.14–5.04).Conclusions and Relevance: Consistent with previous studies, signs of retinopathy are common in US persons without diabetes. Risk factors for retinopathy signs include gender, blood pressure, HbA1c and history of stroke.

14 February 2021 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
JSJane Scheetz
Jane Scheetz
MHMingguang He
Mingguang He
PWPeter Wijngaarden
Peter Wijngaarden
Click on the article title to read more.

4 September 2019 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
YJYu Jiang
Yu Jiang
DWDecai Wang
Decai Wang
WWWei Wang
Wei Wang
FCFeng Chen
Feng Chen
LWLanhua Wang
Lanhua Wang
MHMingguang He
Mingguang He
Purpose To investigate the 5-year changes in static and dynamic anterior segment optical coherence tomography (AS-OCT) parameters and their predictors. Methods This was a prospective, population-based cohort study of people aged 50 years and older residing in the Liwan District, Guangzhou, China. Standardised AS-OCT scans were performed in November 2008 and November 2013 under dark and light conditions. Customised software was used to analyse horizontal AS-OCT images. Parameters in dark and measurements of light-to-dark changes were used for analyses. Results A total of 186 (71.8%) subjects underwent AS-OCT twice, 5 years apart and were included for analyses. The mean age in 2008 was 64.7±7.0 years, and 60.2% were women. The anterior chamber width (ACW) decreased from 11.74±0.44 mm in 2008 to 11.60±0.37 mm in 2013 (p=0.001). There was a trend towards a decrease in dynamic capacity (light-to-dark changes) in the anterior segment, with decreased iris thickness at 750 µm (ΔIT750), ΔACW, Δ anterior chamber area (ACA) and Δ pupil diameter at 5 years (all p<0.05). After adjusting for age and sex, the following baseline parameters were associated with a greater decrease rate in trabecular iris space area at 500 µm (TISA500) at 5 years: TISA500, IT750 and ACA in dark (p<0.001 for all). Conclusions Anterior chamber angle width decreased and the amount of light-to-dark changes declined during 5-year follow-up. Subjects with greater height, wider angle width and thicker iris at baseline have greater angle narrowing at follow-up.

29 April 2019 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ZZZhuoting Zhu
Zhuoting Zhu
YJYu Jiang
Yu Jiang
WWWei Wang
Wei Wang
JSJane Scheetz
Jane Scheetz
XSXianwen Shang
Xianwen Shang
MHMingguang He
Mingguang He